Currently approved antihelminthic drug effective against MRSA Print
EurekAlert: The paper, published in the journal PLOS ONE, showed that niclosamide, which is on World Health Organization's list of essential medicines, suppressed the growth of dozens of methicillin-resistant Staphylococcus aureus (MRSA) cultures in lab dishes and preserved the lives of nematode worms infected with the superbug. In these tests, both niclosamide and a closely related veterinary parasite drug, oxyclozanide, proved to be as effective (at lower concentrations) as the current last-resort clinical treatment, vancomycin.

...